Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Over the last 12 months, insiders at Disc Medicine, Inc. have bought $14M and sold $25.51M worth of Disc Medicine, Inc. stock.
On average, over the past 5 years, insiders at Disc Medicine, Inc. have bought $12M and sold $28.02M worth of stock each year.
Highest buying activity among insiders over the last 12 months: ORBIMED ADVISORS LLC (director) — $126M. Bitterman Kevin (director) — $24M. Ashiya Mona (director) — $3M.
The last purchase of 222,223 shares for transaction amount of $8M was made by Bitterman Kevin (director) on 2024‑06‑17.
2024-12-16 | Sale | Chief Executive Officer | 12,791 0.0431% | $66.01 | $844,314 | -2.54% | ||
2024-12-02 | Sale | director | 1,957 0.0066% | $64.63 | $126,490 | +0.75% | ||
2024-11-25 | Sale | Chief Medical Officer | 14,183 0.0492% | $65.45 | $928,326 | +0.08% | ||
2024-11-15 | Sale | Chief Medical Officer | 9,158 0.0289% | $59.64 | $546,153 | +8.48% | ||
2024-11-04 | Sale | director | 7,136 0.0221% | $58.61 | $418,206 | +10.70% | ||
2024-11-01 | Sale | director | 201 0.0005% | $46.37 | $9,319 | +36.77% | ||
2024-10-01 | Sale | director | 201 0.0005% | $51.31 | $10,312 | +16.61% | ||
2024-09-16 | Sale | Chief Medical Officer | 1,500 0.0038% | $47.41 | $71,115 | +10.59% | ||
2024-09-03 | Sale | Chief Medical Officer | 1,500 0.004% | $50.59 | $75,885 | +2.13% | ||
2024-09-03 | Sale | director | 1,957 0.0051% | $49.65 | $97,158 | +2.13% | ||
2024-08-01 | Sale | director | 201 0.0005% | $43.44 | $8,731 | +14.57% | ||
2024-07-01 | Sale | director | 201 0.0005% | $46.04 | $9,253 | +4.72% | ||
2024-06-17 | director | 83,334 0.1589% | $36.00 | $3M | +7.24% | |||
2024-06-17 | director | 83,334 0.1589% | $36.00 | $3M | +7.24% | |||
2024-06-17 | director | 222,223 0.4237% | $36.00 | $8M | +7.24% | |||
2024-06-03 | Sale | director | 1,957 0.0037% | $36.08 | $70,608 | +32.16% | ||
2024-05-01 | Sale | director | 201 0.0003% | $28.63 | $5,755 | +65.97% | ||
2024-04-11 | Sale | director | 2,560 0.0043% | $31.80 | $81,407 | +46.54% | ||
2024-03-05 | Sale | director | 26,157 0.1018% | $73.50 | $1.92M | -31.68% | ||
2024-01-23 | Sale | director | 102,500 0.3672% | $67.65 | $6.93M | -27.35% |
ORBIMED ADVISORS LLC | director | 941569 3.1641% | $65.01 | 1 | 0 | |
Ashiya Mona | director | 941569 3.1641% | $65.01 | 1 | 0 | |
Bitterman Kevin | director | 420549 1.4132% | $65.01 | 1 | 2 | |
AI DMI LLC | 10 percent owner | 3141759 10.5578% | $65.01 | 1 | 0 | +100.92% |